Individualized therapy based on the combination of mini‑PDX and NGS for a patient with metastatic AFP‑producing and HER‑2 amplified gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Individualized therapy based on the combination of mini‑PDX and NGS for a patient with metastatic AFP‑producing and HER‑2 amplified gastric cancer

Published:2022-09-27 Issue:5 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhu Xiaodan¹,Xu Xiaoqing¹,Zhang Baonan¹,Dong Yun²,Gong Shixia¹,Gong Tingjie¹,Zhang Feifei³,Jin Chunhui¹

Affiliation:

1. Department of Oncology, Wuxi Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, Jiangsu 214071, P.R. China

2. Department of Pathology, Wuxi Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, Jiangsu 214071, P.R. China

3. Shanghai LIDE Biotech, Co., Ltd., Shanghai 201203, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference33 articles.

1. World Cancer Day: Breast overcancer takes lung cancer as leading cause of worldwidecancer;International Agency for Research on Cancer (IARC),2021

2. Clinicopathological and prognostic characteristics of hepatoid adenocarcinoma of the stomach;Yang;Gastroenterol Res Pract,2014

3. AFP-producing gastric cancer and hepatoid gastric cancer;Wang;Zhonghua Zhong Liu Za Zhi,2017

4. Lymph node metastasis of early submucosal gastric cancer: A report of 290 cases;Jang;World Chin J Dig,2011

5. Advances in the treatment of advanced gastric cancer;Wang;Chin Clin Oncol,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin;Biomedicine & Pharmacotherapy;2023-11

2. Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients;F1000Research;2023-08-08

3. Emerging targets in gastroesophageal adenocarcinoma: what the future looks like;Therapeutic Advances in Medical Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3